Showing results (2171-2180 of 2,217) with videos related to
Sort By:
Pageof 222
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2020
Phase II Study of Combination Obinutuzumab, Ibrutinib, and Venetoclax in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic LeukemiaKerry A Rogers, Ying Huang, Amy S Ruppert, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2023
Unraveling the potential clinical utility of circulating tumor DNA detection in colorectal cancer-evaluation in a nationwide Danish cohortT V Henriksen, C Demuth, A Frydendahl, et al.Acta Dermato-Venereologica|January 1, 1997
Oral terbinafine in toenail dermatophytosis. A double-blind, placebo-controlled multicenter study with 12 months' follow-upE L Svejgaard, F Brandrup, K Kragballe, et al.The Journal of General Physiology|May 25, 2023
Physical activity impacts resting skeletal muscle myosin conformation and lowers its ATP consumptionChristopher T A Lewis, Lee Tabrizian, Joachim Nielsen, et al.Journal of Geriatric Oncology|August 22, 2024
Resiliency among older adults receiving lung cancer treatment (ROAR-LCT): A novel supportive care intervention for older adults with advanced lung cancerCarolyn J Presley, Madison Grogan, Amy Compston, et al.British Journal of Cancer|June 16, 2005
Gene expression signatures for colorectal cancer microsatellite status and HNPCCM Kruhøffer, J L Jensen, P Laiho, et al.Pharmacology, Biochemistry, and Behavior|May 20, 2014
Sleep deprivation impairs the extinction of cocaine-induced environmental conditioning in miceL F Berro, A W Hollais, C L Patti, et al.Bone Research|October 18, 2024
Mapping RANKL- and OPG-expressing cells in bone tissue: the bone surface cells as activators of osteoclastogenesis and promoters of the denosumab rebound effectBilal M El-Masri, Christina M Andreasen, Kaja S Laursen, et al.Cancer Discovery|February 13, 2021
Identification and Therapeutic Targeting of GPR20, Selectively Expressed in Gastrointestinal Stromal Tumors, with DS-6157a, a First-in-Class Antibody-Drug ConjugateKenji Iida, Amr H Abdelhamid Ahmed, Akiko Kawano Nagatsuma, et al.ACS Central Science|June 27, 2022
Unexpectedly Large Contribution of Oxygen to Charge Compensation Triggered by Structural Disordering: Detailed Experimental and Theoretical Study on a Li3NbO4-NiO Binary SystemRyutaro Fukuma, Maho Harada, Wenwen Zhao, et al.Pageof 222